期刊论文详细信息
Trials
Rotterdam Aphasia Therapy Study (RATS) – 3: “The efficacy of intensive cognitive-linguistic therapy in the acute stage of aphasia”; design of a randomised controlled trial
Lonneke M L de Lau1  Peter J Koudstaal2  Evy G Visch-Brink2  Marjolein de Jong-Hagelstein2  Diederik WJ Dippel2  Femke Nouwens2 
[1] Department of Neurology, Slotervaart Hospital, Amsterdam, The Netherlands;Department of Neurology, Erasmus MC – University Medical Center Rotterdam, P.O. Box 2040, Rotterdam, CA, 3000, The Netherlands
关键词: RCT;    Intensity;    Timing;    Treatment;    Cognitive-linguistic therapy;    Stroke;    Aphasia;   
Others  :  1094898
DOI  :  10.1186/1745-6215-14-24
 received in 2012-09-21, accepted in 2012-11-21,  发布年份 2013
PDF
【 摘 要 】

Background

Aphasia is a severely disabling condition occurring in 20 to 25% of stroke patients. Most patients with aphasia due to stroke receive speech and language therapy. Methodologically sound randomised controlled trials investigating the effect of specific interventions for patients with aphasia following stroke are scarce. The currently available evidence suggests that intensive speech and language therapy is beneficial for restoration of communication, but the optimal timing of treatment is as yet unclear.

In the Rotterdam Aphasia Therapy Study-3 we aim to test the hypothesis that patients with aphasia due to stroke benefit more from early intensive cognitive-linguistic therapy than from deferred regular language therapy.

Methods/design

In a single blinded, multicentre, randomised controlled trial, 150 patients with first ever aphasia due to stroke will be randomised within two weeks after stroke to either early intensive cognitive-linguistic therapy (Group A) or deferred regular therapy (Group B). Group A will start as soon as possible, at the latest two weeks after stroke, with a four week period of one hour a day treatment with cognitive-linguistic therapy. In Group B professional speech and language therapy is deferred for four weeks. After this period, patients will follow the conventional procedure of speech and language therapy. Participants will be tested with an extensive linguistic test battery at four weeks, three months and six months after inclusion. Primary outcome measure is the difference in score between the two treatment groups on the Amsterdam-Nijmegen Everyday Language Test, a measure of everyday verbal communication, four weeks after randomisation.

Trial registration

This trial is registered in the Dutch Trial Register (http://www.trialregister.nl webcite), NTR3271.

【 授权许可】

   
2013 Nouwens et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150130180222285.pdf 634KB PDF download
Figure 1. 83KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Vaartjes I, van Dis I, Visseren FLJ, Bots ML: Cardiovascular diseases in The Netherlands in women and men. In Cardiovascular Diseases in The Netherlands in 2011. Facts on Lifestyle and Risk Factors. Edited by Vaartjes I, Dis I, Visseren FLJ, Bots ML. Den Haag: Dutch Heart Foundation; 2011:7-22.
  • [2]Bowen A, Hesketh A, Patchick E, Young A, Davies L, Vail A, Long A, Watkins C, Wilkinson M, Pearl G, Lambon Ralph M, Tyrrell P, ACT NoW investigators: Clinical effectiveness, cost-effectiveness and service users’ perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study). Health Technol Assess 2012, 16:1-160.
  • [3]Brady MC, Kelly H, Godwin J, Enderby P: Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2012, 5:CD000425.
  • [4]Visch-Brink EG, Wielaert S: Impairment directed therapy and/or communicative therapy for impaired functions in aquired aphasia? Stem-, Spraak- en Taalpathol 2005, 13:153-173.
  • [5]Davis GA, Wilcox MJ: Adult Aphasia Rehabilitation: Applied Pragmatics. San Diego, CA: Singular; 1985.
  • [6]de Jong-Hagelstein M, van de Sandt-Koenderman WM, Prins ND, Dippel DW, Koudstaal PJ, Visch-Brink EG: Efficacy of early cognitive-linguistic treatment and communicative treatment in aphasia after stroke: a randomised controlled trial (RATS-2). J Neurol Neurosurg Psychiatry 2011, 82:399-404.
  • [7]Blomert L, Koster C, Kean ML: Amsterdam-Nijmegen Everyday Language Test. Lisse, The Netherlands: Swets & Zietlinger; 1995.
  • [8]Bhogal SK, Teasell R, Speechley M: Intensity of aphasia therapy, impact on recovery. Stroke 2003, 34:987-993.
  • [9]Cherney LR, Patterson JP, Raymer AM: Intensity of aphasia therapy: evidence and efficacy. Curr Neurol Neurosci Rep 2011, 11:560-569.
  • [10]Robey RR: A meta-analysis of clinical outcomes in the treatment of aphasia. J Speech Lang Hear Res 1998, 41:172-187.
  • [11]Teasell R, Bitensky J, Salter K, Bayona NA: The role of timing and intensity of rehabilitation therapies. Top Stroke Rehabil 2005, 12:46-57.
  • [12]Saur D, Lange R, Baumgaertner A, Schraknepper V, Willmes K, Rijntjes M, Weiller C: Dynamics of language reorganization after stroke. Brain 2006, 129:1371-1384.
  • [13]Pulvermuller F, Berthier ML: Aphasia therapy on a neuroscience basis. Aphasiology 2008, 22:563-599.
  • [14]Code C: Multifactorial processes in recovery from aphasia: developing the foundations for a multileveled framework. Brain Lang 2001, 77:25-44.
  • [15]Berthier ML, Garcia-Casares N, Walsh SF, Nabrozidis A, Ruíz de Mier RJ, Green C, Dávila G, Gutiérrez A, Pulvermüller F: Recovery from post-stroke aphasia: lessons from brain imaging and implications for rehabilitation and biological treatments. Discov Med 2011, 12:275-289.
  • [16]Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J: Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005, 86:1681-1692.
  • [17]Berthier ML, Pulvermuller F: Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nat Rev Neurol 2011, 7:86-97.
  • [18]Godecke E, Hird K, Lalor EE, Rai T, Phillips MR: Very early poststroke aphasia therapy: a pilot randomized controlled efficacy trial. Int J Stroke 2012, 7:635-644.
  • [19]Laska AC, Kahan T, Hellblom A, Murray V, von Arbin M: A randomized controlled trial on very early speech and language therapy in acute stroke patients with aphasia. Cerebrovasc Dis Extra 2011, 1:66-74.
  • [20]El Hachioui H, Sandt-Koenderman MW, Dippel DW, Koudstaal PJ, Visch-Brink EG: The ScreeLing: occurrence of linguistic deficits in acute aphasia post-stroke. J Rehabil Med 2012, 44:429-435.
  • [21]De Renzi E, Faglioni P: Normative data and screening power of a shortened version of the Token Test. Cortex 1978, 14:41-49.
  • [22]Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, PA: Lea and Febiger; 1972.
  • [23]Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965, 14:61-65.
  • [24]van de Sandt-Koenderman WM, van Harskamp F, Duivenvoorden HJ, Remerie SC, van der Voort-Klees YA, Wielaert SM, Ribbers GM, Visch-Brink EG: MAAS (Multi-axial Aphasia System): realistic goal setting in aphasia rehabilitation. Int J Rehabil Res 2008, 31:314-320.
  • [25]Visch-Brink EG, Bajema IM: BOX, a Semantic Therapy Program. Lisse, The Netherlands: Swets & Zeitlinger; 2001.
  • [26]Van Rijn M, Booy L, Visch-Brink EG: FIKS, a Phonological Therapy Program. Lisse, The Netherlands: Swets & Zeitlinger; 2000.
  • [27]Van Sabadel EP, Signoret JL, Pillon B: Unusual Stories for Conversation. Paris: Médecine et Sciences Internationales; 1982.
  • [28]Visch-Brink EG, Van de Sandt-Koenderman M: El Hachioui H: ScreeLing. Houten: Bohn Stafleu van Loghum; 2010.
  • [29]Kaplan E, Goodglass H, Weintraub S: Boston Naming Test. Philadelphia-Tokyo: Lippincott, Williams & Wilkins; 2001.
  • [30]Visch-Brink EG, Stronks DL, Denes G: The Semantic Association Test. Amsterdam: Harcourt Assessment B.V; 2005.
  • [31]Swinburn K, Porter G, Howard D: Comprehensive Aphasia Test. New York, NY: Psychology Press; 2004.
  • [32]Luteijn F, Barelds DPF: Groningen Intelligence Test - 2; GIT - 2. Amsterdam: Pearson Assessment and Information B.V; 2004.
  • [33]Kay J, Lesser R, Coltheart M: Psycholinguistic Assessment of Language Processing in Aphasia (PALPA). London: Lawrence Erlbaum Associates; 1992.
  • [34]Schmand B, Groenink SC, Van den Dungen M: Letter fluency: psychometric properties and Dutch standards. Tijdschr Gerontol Geriatr 2008, 39:65-77.
  • [35]Blomert L: Who’s the “expert”? Amateur and professional judgement of aphasic communication. Top Stroke Rehabil 1995, 2:64-71.
  • [36]The EuroQol Group: EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
  • [37]van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
  • [38]Graetz P, De Bleser R, Willmes K: Aachen Aphasia Test. Dutch version. Lisse, The Netherlands: Swets & Zeitlinger; 1991.
  • [39]NVN CBO: Dutch Guideline ‘Diagnostics, Treatment and Care for Stroke Patients’. 2009. Available from: http://www.diliguide.nl/document/230 webcite
  • [40]Blomert L, Kean ML, Koster C, Schokker J: Amsterdam-Nijmegen everyday language test: construction, reliability and validity. Aphasiology 1994, 8:381-407.
  • [41]Netherlands Trials Register. http://www.trialregister.nl/trialreg/index.asp webcite
  文献评价指标  
  下载次数:13次 浏览次数:7次